J&J Spots Potential Of Fate’s Stem Cells, Signs Cancer Deal Worth Up To $3bn
Another Next-Generation Approach to CAR-Ts
Investment from Janssen helps to validate the platform developed by the San Diego-based company.

Investment from Janssen helps to validate the platform developed by the San Diego-based company.